Leaving Scientific Claims Without Clear Responsibility or Supporting Context
Observable evidence: Priority platform, disease-area, program, or clinical-information pages make technical statements without showing who authored or reviewed the material, which company function owns it, when it was last assessed, or where a reader can check supporting publications and approved disclosures. The source discusses experience, expertise, authoritativeness, and trust, but it does not prove that a particular degree or credential is required for search visibility.
Consequence: A specialist reader may be unable to distinguish current company information from older interpretation, identify the person or function accountable for accuracy, or trace a claim back to evidence. That is a concrete trust and usability problem even when no ranking effect is assumed.
Correction: Add truthful attribution where it is useful, identify the relevant reviewer or responsible function, show a meaningful review date, and connect claims to available supporting publications, disclosures, bios, or professional profiles. Use ORCID, PubMed, academic affiliations, or similar references only when they genuinely apply to the contributor and help a reader verify expertise.
Owner: Scientific communications or medical affairs should approve scientific responsibility and wording; content and web teams should implement visible attribution and evidence links; legal, regulatory, or other required reviewers should retain their established decision rights.
Verification: Review a sample of high-value pages as a reader would. Confirm that responsibility, review status, evidence, and current-versus-historical context are visible in the page experience and consistent with the approved source material rather than existing only in hidden metadata.
Severity: critical
Using Broad Search Themes That Do Not Match the Company's Real Science
Observable evidence: Titles, headings, and body copy lean on generic disease, therapy, or biotechnology terms while the company's actual platform, target, pathway, modality, assay, indication, program, or partnership concepts are difficult to locate. The problem is not that a phrase is narrow. It is that the page does not answer a recognizable specialist question with terminology the company can substantiate.
Consequence: Broad pages may attract poorly matched visits while scientists, partners, investors, or other evaluators still lack a clear destination for the specific concept they searched. Important program relationships can remain invisible even when the site has relevant material elsewhere.
Correction: Build the topic map from approved program language, publications, investor materials, partnership questions, internal search behavior, stakeholder interviews, and other legitimate source material. Use Mechanism of Action language only where it accurately describes the science, and separate informational intent from platform, program, partnership, or other decision tasks instead of forcing them onto one page.
Owner: SEO or content strategy should define query-to-page mapping; scientific, program, product, and communications stakeholders should approve terminology, claims, and the intended audience for each destination.
Verification: Compare Search Console queries, internal search terms, stakeholder questions, page titles, and on-page coverage. For each priority concept, confirm that there is a clear primary destination and that broader pages point to specific supporting evidence when that relationship is useful.
Severity: high
Hiding Essential Scientific Information Behind Heavy or Incomplete Delivery
Observable evidence: A page depends on 3D viewers, oversized images, interactive charts, JavaScript-heavy components, or downloads while the essential explanation is missing from accessible page content. Important copy may not appear in rendered HTML, navigation may depend on scripts, and document-only evidence may leave users without enough context before opening a file.
Consequence: Readers and crawlers may struggle to reach, interpret, or connect the information that makes the page useful. The source mentions automatic Core Web Vitals and authority effects, but no supporting URL is provided here, so the defensible finding is a delivery, discoverability, accessibility, or comprehension defect rather than a guaranteed penalty.
Correction: Compare server output with browser-rendered output, reduce avoidable media weight, lazy-load noncritical assets, keep crawlable navigation available, and expose the essential scientific explanation in accessible HTML. Use supporting documents where they add value, but do not make a document the only place for critical context when an on-page explanation is appropriate.
Owner: Web engineering should own rendering, crawlability, and performance implementation; design and data teams should own an accessible presentation; scientific reviewers should confirm that any simplified explanation remains faithful to the approved evidence.
Verification: Test priority templates on representative devices, inspect rendered HTML, crawl internal navigation, and review indexation and page behavior before and after the correction. The supplied example describes an interactive pipeline map taking 8 seconds alongside a 40% visibility decline; because no supporting study URL is included, preserve it as an illustration that still requires source reconciliation rather than evidence of causation.
Severity: high
Keeping Pipeline, Platform, Therapeutic-Area, and Evidence Pages in Silos
Observable evidence: Pipeline overviews, program pages, platform explanations, therapeutic-area content, publications, and milestone updates can each be found, but they rarely link to the related pages that explain how the science fits together. A reader must repeatedly return to top-level navigation or site search to move from a program to its indication, platform, supporting evidence, or update history.
Consequence: The site presents a fragmented model of the portfolio. Readers may miss relevant context, and crawlers may have weaker paths to deep pages that otherwise contain useful scientific or company information.
Correction: Add descriptive contextual links only where a real relationship exists, such as program to indication, indication to platform, platform to publication, milestone update to the current program page, or program page to supporting evidence. Avoid sitewide over-linking, forced anchors, or connections that imply a scientific relationship the source material does not support.
Owner: Content strategy should define the information relationships; CMS or web owners should implement reusable linking patterns; scientific and program stakeholders should validate that each relationship is accurate and current.
Verification: Crawl for orphaned and weakly linked priority pages, review click depth, and manually trace realistic stakeholder journeys from broad science content to specific programs, evidence, and current updates. Record broken or misleading connections as defects rather than relying only on aggregate link counts.
Severity: medium
Publishing Location Pages That Do Not Represent Useful Local Information
Observable evidence: Real laboratories, offices, trial locations, or regional operations lack a useful destination, or the site creates city and region pages whose substantive content is nearly identical apart from the place name. Eligible physical locations may also have incomplete Google Business Profiles, while authoritative office or trial details are scattered across unrelated pages.
Consequence: Someone looking for a real office, laboratory, study location, regional contact, or locally relevant operational detail can reach a vague or mismatched page. Do not infer from this defect that local SEO determines enrollment, hiring, partnership, or other business outcomes.
Correction: Create a dedicated location page only for a genuine location that can offer useful location-specific details. Keep eligible business profiles accurate, and align trial or office information with authoritative company and study sources. Consolidate nominal-market pages that exist primarily to target place names without a distinct user need.
Owner: Clinical operations, facilities, talent, or regional communications should own the underlying location facts; web and local-search owners should maintain page discoverability, consistency, and updates.
Verification: Check addresses, contacts, operational details, trial references, eligibility where applicable, and page uniqueness against authoritative records. Confirm that each location page answers a real local task and does not imply a presence or service that the company has not established.
Severity: medium
Treating Repetitive PR Distribution as a Replacement for Relevant Earned References
Observable evidence: Referring pages are concentrated in syndicated announcements, duplicate release copies, or low-context mentions, while substantive publications, datasets, conference materials, collaborations, expert contributions, and other citable company resources receive little targeted outreach. A link attribute or publication label by itself does not establish the value of a reference.
Consequence: Communications effort can produce repeated copies of the same announcement without helping a specialist audience discover, understand, or verify the underlying science. The source does not provide proof for a fixed SEO value assigned to particular link types, so relevance and editorial context are safer evaluation criteria.
Correction: Center outreach on material that is genuinely worth citing, such as peer-reviewed work, public datasets, conference contributions, scientific collaborations, accurate expert commentary, company milestones, or explanatory resources. Do not manufacture academic endorsement, imply that a publication owes coverage, or treat raw backlink volume as a substitute for editorial relevance.
Owner: Communications and digital PR should own outreach planning; scientific teams should validate technical claims; legal, investor-relations, and other appropriate reviewers should approve regulated or market-sensitive disclosures before promotion.
Verification: Review each meaningful new referring page for topical relevance, editorial context, factual accuracy, and whether it sends readers who have a legitimate reason to engage with the cited material. The source contrasts a firm with 500 press-release links against a competitor with 50 links from high-impact journals; without supporting evidence, retain that comparison only as a reminder that raw counts do not establish quality or causation.
Severity: high
Letting Milestone Information Become Inconsistent Across the Website
Observable evidence: Pipeline, program, platform, newsroom, presentation, and scientific pages use conflicting stages, dates, terminology, or status language for the same asset after a clinical, regulatory, financing, partnership, publication, or data milestone. Older pages remain prominent without a clear review status or historical framing.
Consequence: A partner, investor, scientist, candidate, or other stakeholder may not be able to tell which statement is current. The source refers to freshness as a universal ranking factor, but no supporting source URL is supplied, so the immediate and verifiable risk is conflicting company information and reduced trust.
Correction: Maintain a content inventory that connects each material milestone to the pages and documents that depend on it. When an approved update occurs, review every affected destination, preserve historical reporting where needed, and label current versus archived context instead of silently rewriting earlier disclosures.
Owner: Corporate communications or content governance should coordinate the update process; scientific, clinical, regulatory, investor-relations, legal, and program owners should approve the information within their remit.
Verification: After a material change, search the site for the program name, old status language, milestone terminology, and outdated snippets. Compare current and historical pages with approved source material, document any intentional differences, and confirm that the live experience no longer presents contradictory current claims.
Severity: medium
